5-Aminolevulinic Acid

5-氨基酮戊酸

Report date: 2026/05/09 20:00:18

Base Information

Drug Name5-Aminolevulinic Acid
Drug Alias NameALAaminolevulinic acid5-ALA - SonALAsense5-Aminolevulinic acid - SonALAsenseSONALA-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhotosensitizers
TargetsNot applicable
Therapy Area/IndicationsAortic valve diseasesOral Squamous Cell CarcinomaDiffuse midline glioma +[17] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited KingdomIndia +[4] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesSonALAsense IncIvy Brain Tumor Center
China Registration ClassN/A

Develop Information

Active CompaniesAlpheus Medical IncSbi Pharmaceuticals Co LtdUniversity Of Oxford +[6] 
Inactive CompaniesRothman Orthopaedic InstituteSonALAsense Inc
Active IndicationsAortic valve diseasesOral Squamous Cell CarcinomaHeart Diseases +[11] 
Inactive IndicationsDiffuse midline gliomaAcne VulgarisShoulder Pain +[6] 

Other Information

ATC CodeN/A
Related LinksN/A